Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
ASX:APZ / ASPEN GROUP CURRENT REPORT (Current Report)

2018-08-01 sec.gov
Current Report UNITED STATES
APZ

0
ASX:APZ / ASPEN GROUP CURRENT REPORT (Current Report)

2018-07-25 sec.gov
Current Report UNITED STATES
APZ

0
ASX:APZ / ASPEN GROUP PROSPECTUS SUPPLEMENT (Prospectus)

2018-07-19 sec.gov
Prospectus Supplement Filed pursuant to Rule 424(b)(5) Registration No. 333-224230 PROSPECTUS SUPPLEMENT (To the Prospectus dated April 18, 2018)
APZ

0
ASX:APZ / ASPEN GROUP CURRENT REPORT (Current Report)

2018-07-19 sec.gov
Current Report UNITED STATES
APZ

0
ASX:APZ / ASPEN GROUP ANNUAL REPORT (Annual Report)

2018-07-13 sec.gov
Annual Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION
APZ

0
Aspen Group Inc. 2018 Q4 - Results - Earnings Call Slides

2018-07-13 seekingalpha
The following slide deck was published by Aspen Group Inc. in conjunction with their 2018 Q4 earnings call.
APZ ASPU

0
Aspen Group Inc. (ASPU) CEO Michael Mathews on Q4 2018 Results - Earnings Call Transcript

2018-07-13 seekingalpha
Good day ladies and gentlemen, and welcome to the Aspen Group Inc., Conference Call. At this time all participants are in a listen-only mode. Later we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions] As a reminder, this conference is being recorded.
APZ ASPU

0
ASX:APZ / ASPEN GROUP CURRENT REPORT (Current Report)

2018-07-12 sec.gov
Current Report UNITED STATES
APZ

0
Aspen Group Revenue Growth Rate Accelerates in Q4 to 68%

2018-07-12 globenewswire
NEW YORK, July 12, 2018 (GLOBE NEWSWIRE) -- Aspen Group, Inc. (Nasdaq:ASPU), a post-secondary education company, today announced financial results for its 2018 fiscal fourth quarter ended April 30, 2018, highlighted by revenue of $7,225,029, an increase of 68% year-over-year. Aspen Group also announced its full year results which are included in the consolidated financial statements at the end of this press release.
APZ ASPU

7
Aspen Group to Announce Fiscal Year 2018 and 4th Quarter Results on Thursday, July 12th

2018-06-27 globenewswire
NEW YORK, June 27, 2018 (GLOBE NEWSWIRE) -- Aspen Group, Inc. (Nasdaq:ASPU), a post-secondary education company, will host a conference call to discuss its fiscal year 2018 and 4th quarter financial results and business outlook on Thursday, July 12, 2018, at 4:30 p.m. (ET). Aspen will issue a press release reporting results after the market closes on Thursday, July 12.
APZ ASPU

6
ASX:APZ / ASPEN GROUP CURRENT REPORT (Current Report)

2018-06-14 sec.gov
Current Report UNITED STATES
APZ

6
ASX:APZ / ASPEN GROUP null

2018-05-31 sec.gov
Acceleration Request Aspen Group, Inc. 720 South Colorado Blvd., Suite 1150N Denver, CO 80246 April 16, 2018
APZ

6
ASX:APZ / ASPEN GROUP null

2018-05-31 sec.gov
begin 644 filename1.pdf M)5!$1BTQ+C4-)>+CS],-"C<@,"!O8FH-/#PO3&EN96%R:7IE9" [email protected],S$Y M-34O3R [email protected],C
APZ

7
United States University Announces the Appointment of Dr. Dianna Scherlin as Dean of the College of Nursing

2018-05-07 globenewswire
NEW YORK, May 07, 2018 (GLOBE NEWSWIRE) -- Aspen Group, Inc. (Nasdaq:ASPU), a post-secondary education company, today announced that United States University (USU) has appointed Dr. Dianna Scherlin, DNP, MS, BS, RN as Dean of its burgeoning College of Nursing.
APZ ASPU

Related Articles

BLDP: Ballard Power Systems Analysis and Research Report

2018-08-13 - Asif

Core Business At Ballard, Ballard Power Systems is building a clean energy growth company. Ballard Power Systems is recognized as a world leader in proton exchange membrane (“PEM”) fuel cell power system development and commercialization. The company's principal business is the design, development, manufacture, sale and service of PEM fuel cell products for a variety of applications, focusing on its power product markets of Heavy-Duty Motive (consisting of bus, truck, rail and marine applications), Portable Power, Material Handling and Backup Power, as well as the delivery of Technology Solutions, including engineering services, technology transfer, and the license and sale of its extensive intellectual property portfolio and fundamental knowledge for a variety of fuel cell applications. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. The hydrogen fuel can be obtained from natural g...

MARA: Marathon Patent Group Analysis and Research Report

2018-08-13 - Asif

Overview Marathon Patent Group was incorporated in the State of Nevada on February 23, 2010 under the name Verve Ventures, Inc. On December 7, 2011, the company changed its name to American Strategic Minerals Corporation and were engaged in exploration and potential development of uranium and vanadium minerals business. In June 2012, the company discontinued its minerals business and began to invest in real estate properties in Southern California. In October 2012, the company discontinued its real estate business when its former CEO joined the firm and the company commenced its IP licensing operations, at which time the Company’s name was changed to Marathon Patent Group, Inc. On November 1, 2017, the company entered into a merger agreement with Global Bit Ventures, Inc. (“GBV”), which is focused on mining digital assets. Marathon Patent Group has since purchased its cryptocurrency mining machines and established a data center in Canada to mine digital assets. Following the me...

ECYT: Endocyte Analysis and Research Report

2018-08-13 - Asif

Business and Organization Endocyte, Inc. is a biopharmaceutical company and leader in developing targeted therapies for the treatment of cancer. The Company uses drug conjugation technology to create novel therapeutics and companion imaging agents for personalized targeted therapies. The agents actively target receptors that are over-expressed on diseased cells relative to healthy cells, such as prostate specific membrane antigen (“PSMA”) in prostate cancer. This targeted approach is designed to safely enable the delivery of highly potent drug payloads. The companion imaging agents are designed to identify patients whose disease over-expresses the target of the therapy and who are therefore more likely to benefit from treatment. In September 2017, the Company entered into a Development and License Agreement (the “License Agreement”) with ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH (“ABX”), pursuant to which the Company acquired exclusive ...